Carotid Atherosclerosis Clinical Trial
Official title:
Potential Impact of Neuroimmune and Autophagic Alterations on the Progression and Severity of Human Atherosclerotic Process
NCT number | NCT03922698 |
Other study ID # | LMB06 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | June 1, 2019 |
Est. completion date | June 30, 2022 |
The hypothesis of this study is that neural regulations of the atherosclerotic plaque, identified in the murine model of atherosclerosis, could also exist in human pathology. The dysregulation status of the autonomic nervous system is typical of several cardiovascular diseases, but the role it exerts in the modulation of important mechanisms at the basis of the atherosclerotic process progression has not been investigated yet. The main aim of this study will be to investigate, in the atherosclerotic plaque, the alterations of inflammatory and immune processes, the neural modulations and the presence of dysregulations of the autophagic process. The investigators will also associate the potential presence of neural modulations of the plaque to its stability/instability, from a clinical-translational point of view. Finally, the investigators aim at providing a solid basis for the development of novel therapeutic strategies, which could reduce the elevated health and welfare costs for the clinical management of cardiovascular pathologies such as atherosclerosis.
Status | Recruiting |
Enrollment | 50 |
Est. completion date | June 30, 2022 |
Est. primary completion date | June 30, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 45 Years to 90 Years |
Eligibility | Inclusion Criteria: - age = 45 and = 90 years; - patients with severe (70-99%) carotid stenosis, diagnosed with color doppler echography or angio-MRI or angiography; - written informed consent. Exclusion Criteria: - carotid stenosis <70% at carotid bifurcation or diagnosed with color doppler echography or angio-MRI or angiography; - severe neoplasia; - participation to other clinical trial, ongoing or terminated less than one month before enrolment in this study. |
Country | Name | City | State |
---|---|---|---|
Italy | IRCCS Neuromed | Pozzilli |
Lead Sponsor | Collaborator |
---|---|
Neuromed IRCCS |
Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Characterization of the neuro-modulation of immune system in atherosclerosis | Immunohistochemistry and immunofluorescence of the autonomic nervous and immune systems in the atherosclerotic plaque, and flow cytometry analysis of circulating immune cells. | At enrollment | |
Primary | Characterization of the autophagic process and correlation with neural modulations of the stability/instability plaque | Expression of autophagic markers and immunohistochemical analysis of the atherosclerotic plaque. | At enrollment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03248401 -
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
|
Phase 4 | |
Withdrawn |
NCT03630835 -
99m Tc-ANNexin-V-128 Scintigraphy for the Identification of Complicated Carotid Atherosclerotic Plaques
|
Phase 2/Phase 3 | |
Completed |
NCT02722720 -
Carotid Arteries Stenting Complications: Transradial Approach Versus Transfemoral
|
N/A | |
Completed |
NCT01893489 -
Visualization of Carotid Atherosclerosis by 68Ga-MSA
|
Phase 1 | |
Withdrawn |
NCT00861159 -
RLIP76 in Human Serum in Adults With Rheumatologic Diseases
|
N/A | |
Recruiting |
NCT01743404 -
Study of Anti-atherosclerotic Activity of Inflaminat in Asymptomatic Participants With Subclinical Atherosclerosis
|
Phase 2 | |
Completed |
NCT00636766 -
Diagnosis and Therapy of Vulnerable Atherosclerotic Plaque
|
N/A | |
Recruiting |
NCT06166121 -
Study on Hyperlipidemia Combined With Carotid Atherosclerosis With ShenJu Granules
|
N/A | |
Withdrawn |
NCT03382249 -
Sonodynamic Therapy Manipulates Atherosclerosis Regression Trial on Patients With Carotid Atherosclerotic Plaques
|
Phase 1/Phase 2 | |
Recruiting |
NCT04679727 -
The Carotid Artery Multi-modality Imaging Prognostic (CAMP) Study
|
||
Withdrawn |
NCT02995642 -
Targeted PET/CT and PET/MRI Imaging of Vascular Inflammation
|
Phase 2 | |
Suspended |
NCT01000181 -
Imaging 61CuATSM Uptake in Atherosclerotic Plaque Using PET-CT
|
N/A | |
Completed |
NCT00001368 -
Potential Risk Factors for Stroke
|
Phase 1 | |
Recruiting |
NCT04537403 -
PET Detection of CCR2 in Human Atherosclerosis
|
Phase 1 | |
Recruiting |
NCT05800821 -
Prediction of Cerebral Hyperperfusion Syndrome After Carotid Revascularization Using Deep Learning
|
||
Completed |
NCT00147797 -
Influence of Pravastatin on Carotid Artery Structure and Function in HIV-infected Patients Under Antiretroviral Therapy
|
N/A | |
Completed |
NCT00147251 -
Stop Atherosclerosis in Native Diabetics Study
|
Phase 4 | |
Completed |
NCT00180518 -
ACCULINK for Revascularization of Carotids in High Risk Patients "The ARCHeR Trial"
|
Phase 2/Phase 3 | |
Completed |
NCT05230576 -
Intelligent Detection of Carotid Plaque and Its Stability Based on Deep Learning Dynamic Ultrasound Scanning
|
||
Terminated |
NCT03764306 -
New Ischemic Cerebral Lesions After Endarterectomy vs. Stenting for the Treatment of Symptomatic Carotid Stenosis
|
N/A |